Athira Pharma Inc (ATHA) Live Share Price, Invest From India

Athira Pharma Inc Stock Performance

as on January 10, 2026 at 7:59 am IST

Day's Low
Day's High
$6.75
Day's Price Range
$7.35
$6.64
-1.66%
Downside
10.69%
Upside
52 Week's Low
52 Week's High
$2.20
52-Week Price Range
$8.36
$6.64
66.87%
Downside
25.90%
Upside

Athira Pharma Inc share price movements today

Previous Close: $7.19
Open: $7.32
Volume: 769.6K
Day's Low - High: $6.75 - $7.35
52 Week Low - High: $2.20 - $8.36

Athira Pharma Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Athira Pharma Inc Stock Fundamentals & Key Indicators

Check Athira Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Athira Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Athira Pharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Athira Pharma Inc	BUY	$-	NA	NA	0.00%
Insmed Inc	BUY	$31.7B	343.73%	NA	-210.54%
Alnylam Pharmaceuticals Inc	BUY	$44.5B	140.06%	143.09	8.45%
Vertex Pharmaceuticals Inc	BUY	$112.4B	101.33%	28.81	32.94%
Regeneron Pharmaceuticals Inc	BUY	$79.7B	50.01%	18.18	31.41%

Analyst Recommendation on Athira Pharma Inc Stock

Based on 12 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Athira Pharma Inc. Average target price of $4

Athira Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Athira Pharma Inc.

What analysts predicted

-66%DOWNSIDE

Target Price

Current Price

$6.64

Analyzed by

12 Analysts

Target

$4.00

Athira Pharma Inc target price $4, a slight downside of -66% compared to current price of $6.64. According to 12 analysts rating.

Athira Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	1	-	-	-	0	-	-	-
Gross Profit	0	0	1	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-29	-32	-27	-26	-26	-28	-15	-9	-6	-6
Net Profit Margin	0.00%	0.00%	-1647.64%	0.00%	0.00%	0.00%	-1549.90%	0.00%	0.00%	0.00%

Athira Pharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-2	0	-1	0	0
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-5	-5	-19	-54	-95	-117	-96
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Athira Pharma Inc

Funds	Holdings
Susquehanna International Group, LLP	0.02%
Northern Trust Corp	0.01%
Vanguard Group Inc	0.39%
Simplify Asset Management Inc.	0.38%
BlackRock Inc	0.1%

See all

Athira Pharma Inc News & Key Events

Insights on Athira Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ATHA stock has moved up by 74.4%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 811.3% return, outperforming this stock by 893.4%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 169.7% return, outperforming this stock by 150.3%

About Athira Pharma Inc

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and slow neurodegeneration. Its approach is designed to modulate the neurotrophic hepatocyte growth factor (HGF) system, which is critical to normal brain function. The Company’s lead drug candidate is ATH-1105. ATH-1105 is a novel, orally available, brain-penetrant small-molecule drug candidate designed to positively modulate the neurotrophic HGF system for the potential treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD). ATH-1105 is in development for the potential treatment of ALS. Its ATH-1020 is a novel, orally available small molecule drug candidate designed to positively modulate the neurotrophic HGF system. It has evaluated several other compounds in preclinical discovery and development for neurodegenerative diseases and other indications.

Organisation	Athira Pharma Inc
E-voting on shares	Click here to vote

FAQs

What is Athira Pharma Inc share price today?

Athira Pharma Inc share price today is $6.64 as on January 10, 2026 at 2:29 am IST at the close of the market. Athira Pharma Inc share today touched a day high of $7.35 and a low of $6.75.

What is the 52 week high and 52 week low for Athira Pharma Inc share?

Athira Pharma Inc share touched a 52 week high of $8.36 on December 18, 2025 and a 52 week low of $2.2 on April 17, 2025. Athira Pharma Inc stock price today i.e. January 10, 2026 at 2:29 am IST is closed at $6.64,which is 20.57% down from its 52 week high and 201.82% up from its 52 week low.

How to invest in Athira Pharma Inc Stock (ATHA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Athira Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Athira Pharma Inc Shares that will get you 0.2259 shares as per Athira Pharma Inc share price of $6.64 per share as on January 10, 2026 at 2:29 am IST.

What is the minimum amount required to buy Athira Pharma Inc Stock (ATHA) from India?

Indian investors can start investing in Athira Pharma Inc (ATHA) shares with as little as ₹93.289 or $1 (as of April 17, 2026 at 8:27 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹932.89 in Athira Pharma Inc stock (as per the Rupee-Dollar exchange rate as on April 17, 2026 at 8:27 am IST). Based on Athira Pharma Inc share’s latest price of $6.64 as on January 10, 2026 at 2:29 am IST, you will get 1.5060 shares of Athira Pharma Inc. Learn more about fractional shares .